[How to capture cytogenetic and molecular abnormalities into ProMISe database for hematological malignancies: Guidelines from the francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)]

MLA

Nicole, Raus, et al. “[How to Capture Cytogenetic and Molecular Abnormalities into ProMISe Database for Hematological Malignancies: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].” Bulletin Du Cancer, vol. 107, no. 1S, Apr. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........4514376b524a17a0d35e4d817b56b22b&authtype=sso&custid=ns315887.

APA

Nicole, R., Micheline, K., Réda, C., Carole, D., Maguy, P., Anne, W., Ibrahim, Y.-A., & Micha, S. (2019). [How to capture cytogenetic and molecular abnormalities into ProMISe database for hematological malignancies: Guidelines from the francophone society of bone marrow transplantation and cellular therapy (SFGM-TC)]. Bulletin Du Cancer, 107(1S).

Chicago

Nicole, Raus, Karam Micheline, Chebel Réda, Dantin Carole, Pereira Maguy, Wallart Anne, Yakoub-Agha Ibrahim, and Srour Micha. 2019. “[How to Capture Cytogenetic and Molecular Abnormalities into ProMISe Database for Hematological Malignancies: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].” Bulletin Du Cancer 107 (1S). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........4514376b524a17a0d35e4d817b56b22b&authtype=sso&custid=ns315887.